Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
NCT00200538
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Dementia
Interventions
DRUG:
memantine
Sponsor
Nantes University Hospital